Tigran Poghosyan

Dr. Tigran Poghosyan

Department of Digestive, Oncologic and Bariatric Surgery,AP-HP, Hôpital Européen Georges Pompidou and UFR Paris Descartes,Université de Paris, 20 Rue Leblanc, 75015 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in The Lancet
Verified
Journal Article
Closed access
MRMaud Robert
Maud Robert
PEPhilippe Espalieu
Philippe Espalieu
EPElise Pelascini
Elise Pelascini
RCRobert Caiazzo
Robert Caiazzo
ASAdrien Sterkers
Adrien Sterkers
EDEmmanuel Disse
Emmanuel Disse

1 October 2011 in Journal of Visceral Surgery
Verified
Journal Article
Closed access
TPTigran Poghosyan
Tigran Poghosyan
SGSebastien Gaujoux
Sebastien Gaujoux
MCM. Chirica
M. Chirica
NMN. Munoz-Bongrand
N. Munoz-Bongrand
ESE. Sarfati
E. Sarfati
PCP. Cattan
P. Cattan

20 August 2020 in Obesity
Verified
Journal Article
Open access
PDF file
SCSébastien Czernichow
Sébastien Czernichow
NBNathanael Beeker
Nathanael Beeker
CRClaire Rives‐Lange
Claire Rives‐Lange
EGEmmanuel Guerot
Emmanuel Guerot
JDJean‐Luc Diehl
Jean‐Luc Diehl
TIThe AP‐HP / Universities / Inserm COVID‐19 research collaboration and AP‐HP Covid CDR Initiative
The AP‐HP / Universities / Inserm COVID‐19 research collaboration and AP‐HP Covid CDR Initiative
Objective: Preliminary data from different cohorts of small sample size or with short follow‐up indicate poorer prognosis in people with obesity compared with other patients. This study aims to precisely describe the strength of association between obesity in patients hospitalized with coronavirus disease 2019 (COVID‐19) and mortality and to clarify the risk according to usual cardiometabolic risk factors in a large cohort.Methods: This is a prospective cohort study including 5,795 patients aged 18 to 79 years hospitalized from February 1 to April 30, 2020, in the Paris area, with confirmed infection by severe acute respiratory syndrome coronavirus 2. Adjusted regression models were used to estimate the odds ratios (ORs) and 95% CIs for the mortality rate at 30 days across BMI classes, without and with imputation for missing BMI values.Results: Eight hundred ninety‐one deaths had occurred at 30 days. Mortality was significantly raised in people with obesity, with the following ORs for BMI of 30 to 35 kg/m2, 35 to 40 kg/m2, and >40 kg/m2: 1.89 (95% CI: 1.45‐2.47), 2.79 (95% CI: 1.95‐3.97), and 2.55 (95% CI: 1.62‐3.95), respectively (18.5‐25 kg/m2 was used as the reference class). This increase holds for all age classes.Conclusions: Obesity doubles mortality in patients hospitalized with COVID‐19.

1 December 2017 in Cell Transplantation
Verified
Journal Article
Open access
JCJonathan Catry
Jonathan Catry
MLMinh Luong-Nguyen
Minh Luong-Nguyen
LALousineh Arakelian
Lousineh Arakelian
TPTigran Poghosyan
Tigran Poghosyan
PBPatrick Bruneval
Patrick Bruneval
PCPierre Cattan
Pierre Cattan
Tissue engineering appears promising as an alternative technique for esophageal replacement. Mesenchymal stem cells (MSCs) could be of interest for esophageal regeneration. Evaluation of the ability of an acellular matrix seeded with autologous MSCs to promote tissue remodeling toward an esophageal phenotype after circumferential replacement of the esophagus in a mini pig model. A 3 cm long circumferential replacement of the abdominal esophagus was performed with an MSC-seeded matrix (MSC group, n = 10) versus a matrix alone (control group, n = 10), which has previously been matured into the great omentum. The graft area was covered with an esophageal removable stent. A comparative histological analysis of the graft area after animals were euthanized sequentially is the primary outcome of the study. Histological findings after maturation, overall animal survival, and postoperative morbidity were also compared between groups. At postoperative day 45 (POD 45), a mature squamous epithelium covering the entire surface of the graft area was observed in all the MSC group specimens but in none of the control group before POD 95. Starting at POD 45, desmin positive cells were seen in the graft area in the MSC group but never in the control group. There were no differences between groups in the incidence of surgical complications and postoperative death. In this model, MSCs accelerate the mature re-epitheliazation and early initiation of muscle cell colonization. Further studies will focus on the use of cell tracking tools in order to analyze the becoming of these cells and the mechanisms involved in this tissue regeneration.

5 December 2012 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
NVNicolas Veyrie
Nicolas Veyrie
TPTigran Poghosyan
Tigran Poghosyan
NCNicola Corigliano
Nicola Corigliano
GCGuillaume Canard
Guillaume Canard
SSStephane Servajean
Stephane Servajean
JBJean‐Luc Bouillot
Jean‐Luc Bouillot

1 June 2017 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
TPTigran Poghosyan
Tigran Poghosyan
CCClementine Caille
Clementine Caille
DMDavid Moszkowicz
David Moszkowicz
MHMouna Hanachi
Mouna Hanachi
CCClaire Carette
Claire Carette
JBJean-Luc Bouillot
Jean-Luc Bouillot